POET Technologies closed at $11.86 on June 8, 2026, down $3.62 — a brutal -23.36% in a single session and the steepest drop on my watchlist that day. When a name falls nearly a quarter in an afternoon, the first question I ask is whether it's the tape or the company. Here it was emphatically the company: this was not a macro selloff but a stack of POET-specific events landing at once.
By Ruslan Averin.
This is Ruslan Averin's POET stock analysis — here is how I read the crash.
POET Technologies (NASDAQ:POET) is a photonics and optical-interconnect play — a speculative, story-driven corner of the chip supply chain. That profile makes its valuation acutely sensitive to dilution and credibility shocks, which is exactly what hit. My POET stock analysis below isolates the three drivers.
| Metric | Value |
|---|---|
| Price | $11.86 |
| Change | -$3.62 (-23.36%) |
| Sector | Photonics / optical interconnect |
| Risk profile | Speculative |
Why did POET Technologies (POET) stock fall on June 8, 2026?
Three company-specific catalysts, not the macro: first, dilution — POET closed a sizable $400M registered direct offering of common shares plus warrants, priced at $21.00 per share-plus-warrant, with warrants exercisable at $26.25 over a three-year term. Second, mounting securities class-action lawsuits allege POET misled the market between April 1 and April 27, 2026 about business strength, PFIC tax status, and key commercial agreements, with a June 29 deadline to appoint lead plaintiffs. Third, lingering fallout from a canceled contract with Marvell Semiconductor earlier in the year.
What does the POET crash mean for investors?
Dilution at a discount, active litigation, and a lost marquee customer is a credibility cluster, not a single bad headline. Each item independently pressures the equity; together they reprice the entire risk premium.
Part of Ruslan Averin's June 8, 2026 market selloff analysis.
Bottom line: I read this as a credibility-driven repricing in a speculative name, not a buy-the-dip setup — but I hold no shares and treat photonics story stocks as strictly position-sized risk.